Which of the following drugs has been found to increase the survival in locally advanced pancreatic cancer?
Gemcitabine is currently the standard of care for patients with metastatic pancreatic cancer.
Doxorubicin
Streptozocin
Gemcitabine
Paclitaxel
Pancreas